Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
in reduced rates of death and MI compared with conservative care.1 Furthermore, the upstream use of platelet glycoprotein IIb / IIIa (Gp IIb / IIIa ) inhibitors (tirofiban or eptifibatide) prior to angiography ...
%, age 65±14 years) and 855 with heparin (males 82%, 63±12 years). In group 1, the use of glycoprotein IIb / IIIa inhibitors was only 4%, compared to 55% (p ...
, intrinsic glycoproteins such as glycoprotein (GP) IIb / IIIa extrude, serving as platelet receptors for activating and inhibiting agents. The dense tubular system is the equivalent of the smooth endoplasmic ...
glycoprotein (GP) IIb / IIIa receptor blockers and unfractionated heparin (Table 2). Analysis of the potential interaction between thrombolytic therapy and GP IIb / IIIa receptor blockers and bleeding risk revealed ...
formation7–9. This appears to be mediated by glycoprotein IIb / IIIa (GPIIb/ IIIa ) receptors, which are expressed exclusively on platelet membranes10. Activation results in the binding of fibrinogen molecules ...
. Effects of platelet glycoprotein IIb / IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute ...
and adrenaline receptors mediate hemostasis and platelet aggregation at the site of injury through glycoproteins IIb / IIIa . They are protease independent receptors that are not affected by aprotinin treatment ...
by Unstable Signs and Symptoms study; PURSUIT, Platelet Glycoprotein IIb / IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy trial; and PARAGON, Platelet IIb / IIIa Antagonist for the Reduction ...
cardiology (bare metal evolving to drug-eluting stents) as well as in pharmaco-therapy, particularly anti- platelet therapy. Agents including clopidogrel and glycoprotein IIb / IIIa receptor inhibitors have been ...
of unstable angina. Glycoprotein IIb / IIIa receptor antagonists are a new class of platelet inhibitors that are more potent than aspirin, because they target the final common pathway of platelet aggregation. Low ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!